Ad5-NOS gene therapy (Schering AG)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAd5-NOS gene therapy (Schering AG)

Drug Alias NameAd5-NOS gene therapy (Schering AG)Ad5-NOS gene therapy (Schering AG)Ad5-NOS gene therapy (Schering AG)gene therapy (Schering AG)gene therapy (Schering AG) +[6]

ClassificationBiologics

Mechanisms of ActionNitric oxide synthesis modulators

TargetsUpdating

Therapy Area/IndicationsArterial Occlusive DiseasesMyocardial Infarction

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBayer Schering Pharma AG

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBayer Schering Pharma AG

Active IndicationsN/A

Inactive IndicationsArterial Occlusive DiseasesMyocardial Infarction

Other Information

ATC CodeN/A